Medline Inc (FRA:L10)
€ 32.6 +1.6 (+5.16%) Market Cap: 28.89 Bil Enterprise Value: 45.03 Bil PE Ratio: 52.32 PB Ratio: 2.91 GF Score: 22/100

Medline Inc at Goldman Sachs Healthcare Conference Transcript

Jun 09, 2026 / 02:40PM GMT
Release Date Price: €28.6 (+0.70%)
David Roman
Goldman Sachs - Analyst

Good morning, everybody. Very pleased to have the management team from Medline here, Jim Boyle, Chief Executive Officer; and Mike Drazin, Chief Financial Officer. I want to keep this as interactive as possible -- should there be any questions, obviously, feel free to raise your hand, we'll get a mic over to you for the benefit of people participating via webcast.

Questions & Answers

David Roman
Goldman Sachs - Analyst

A lot to talk about Medline and kind of your journey here into the public markets. But I wanted just to start with -- it's very topical we're getting a lot of questions on is just quality remediation, the warning letter that you just received. Maybe just sort of frame for investors what's going on? How do we contextualize this? Why isn't this a bigger problem? How does this not metastasize, et cetera??

James Boyle
Medline Inc - Chief Executive Officer, Director

Yes. Thank you for asking, and thank you all for being here. Quality of Medline is paramount,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot